Sector Expert: Colin Lee Novick

CJ PARTNERS

Image: Colin Lee Novick

Colin Lee Novick is cofounder and managing director of CJ PARTNERS. As an American born in South Korea and raised in Japan, Novick matriculated from Japanese public school to study at Cornell University. After working as a management consultant at Deloitte Tohmatsu Consulting within the Financial Services Industry Group for three years, Novick sought out a new industry at SMBC Nikko Securities, where he facilitated mergers and acquisitions. In 2012, Novick and cross-cultural colleague Jason David Sieger founded CJ PARTNERS Inc. to assist in Japan Inc.'s development.



Recent Interviews

Regenerative Medicine in Japan: CJ PARTNERS' Colin Lee Novick (8/5/15)
sideways-blue-stemcell580

Regenerative medicine is just beginning to be understood by governments and investors alike. Last autumn, new regulations took effect in Japan that promise to speed patient access to some of these new therapies. In this interview with The Life Sciences Report, Colin Lee Novick, managing partner with CJ PARTNERS, describes Japan's regenerative medicine frontier and lists investment-worthy companies that are pushing the boundaries.

Recent Quotes

"RGS is actively seeking Japanese partners for its adipose-derived mesenchymal stem cell osteoarthritis drug, Progenza."

The Life Sciences Report Interview with Colin Lee Novick (8/5/15)
more >



Due to permission requirements, not all quotes are shown.